凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
莱茵生物(002166)公告正文

莱茵生物2007年第三季度报告

公告日期 2007-10-27
股票简称:莱茵生物 股票代码:002166
    
                               桂林莱茵生物科技股份有限公司2007年第3季度季度报告全文

    1重要提示
    1.1本公司董事会、监事会及董事、监事、高级管理人员保证本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性负个别及连带责任。
    1.2没有董事、监事、高级管理人员对本报告内容的真实性、准确性、完整性无法保证或存在异议。
    1.3公司全体董事亲自出席了本次审议季度报告的董事会。
    1.4公司第三季度财务报告未经会计师事务所审计。
    1.5公司负责人秦本军、主管会计工作负责人周庆伟及会计机构负责人(会计主管人员)郑辉声明:保证季度报告中财务报告的真实、完整。
    2公司基本情况
    2.1主要会计数据及财务指标

                                                                                                                                       单位:(人民币)元
                                                            2007.9.30                             2006.12.31                        增减幅度(%)
                  总资产                                              349,703,545.00                         169,210,376.07                             106.67%
                股东权益                                              240,857,780.87                          78,986,372.04                             204.94%
                    股本                                               64,766,880.00                          48,266,880.00                              34.18%
               每股净资产                                                       3.72                                   1.64                             126.83%
                                                                              比上年同期增减                                           比上年同期增减
                                                  2007年7-9月                                               2007年1-9月
                                                                                     (%)                                                   (%)
               营业总收入                                  26,712,669.02                     -15.22%                97,844,489.75                         7.85%
                  净利润                                    2,703,752.99                     -46.59%                18,203,876.29                        -7.80%
 经营活动产生的现金流量净额                                 -                             -                         -2,083,803.44                      -140.28%
 每股经营活动产生的现金流量
                                                            -                             -                                -0.032                      -127.27%
                    净额
             基本每股收益                                           0.06                     -40.00%                         0.38                        -7.32%
 扣除非经常性损益后的基本每                                 -                             -                                  0.38                        -5.00%
              股收益
          稀释每股收益                                              0.06                     -40.00%                        0.38                         -7.32%
          净资产收益率                                             1.12%             减少4.29个百分点                      7.56%                  减少17.59个百分点
 扣除非经常性损益后的净资产                                                                                                                       
                                                                   1.40%             减少4.32个百分点                      7.65%                  减少16.93个百分点
              收益率

    注:报告期总股本按64,766,880股计算,上年同期总股本按48,266,880股计算。非经常性损益项目

                                                                                                     单位:(人民币)元
                      非经常性损益项目                                             2007年1-9月金额
营业外收入                                                                                                     525,717.88
营业外支出                                                                                                    -766,673.46
所得税影响金额                                                                                                  18,071.67
                              合计                                                                            -222,883.91
2.2报告期末股东总人数及前十名无限售条件股东持股情况表
                                                                                                               单位:股
                 股东总数                                                                                          12,464
             前10名无限售条件股东持股情况
                 股东名称                         持有无限售条件股份数量                          股份种类
武汉华森塑胶有限公司                                                        260,000             人民币普通股
袁富成                                                                      106,718             人民币普通股
杭厅                                                                         87,500             人民币普通股
关慧林                                                                       51,568             人民币普通股
叶国刊                                                                       48,900             人民币普通股
赵彩娟                                                                       40,000             人民币普通股
叶真                                                                         40,000             人民币普通股
张克强                                                                       38,579             人民币普通股
何玉英                                                                       38,400             人民币普通股
文玉香                                                                       38,200             人民币普通股

    3重要事项
    3.1公司主要会计报表项目、财务指标大幅度变动的情况及原因
    √适用□不适用
    3.1.1报告期内公司资产负债表项目大幅度变动及原因:

            项目          本报告期末               年初数    增减金额( )         增减( %)
  货币资金                155,915,455.4      26,514,193.53   129,401,261.87        488.05%
  应收账款                 37,616,937.54     20,085,656.06    17,531,281.48         87.28%
  其他应收款                4,993,828.02      3,478,929.27     1,514,898.75         43.54%
  长期股权投资              1,030,000.00        520,000.00       510,000.00         98.08%
  在建工程                    451,311.65      1,146,168.20      -694,856.55        -60.62%
  无形资产                 36,337,247.53     15,346,346.87    20,990,900.66        136.78%
  短期借款                 41,000,000.00     29,100,000.00    11,900,000.00         40.89%
  预收款项                  2,627,225.90      6,389,573.62    -3,762,347.72        -58.88%
  其他应付款                5,879,021.21      2,311,462.44     3,567,558.77        154.34%
  其他非流动负债            9,166,368.77      2,634,531.21     6,531,837.56        247.93%
  总资产                  349,703,545.00    169,210,376.07   180,493,168.93        106.67%

    1、货币资金较年初增加488.05%,主要原因是公司发行新股1650万股,募集资金16318.5万元;
    2、应收帐款较年初增加87.28%,主要原因是报告期公司相关大客户的帐期延后所致;
    3、其他应收款较年初增加43.54%,主要原因是公司采购外地生产原料的借支款项增加;
    4、长期股权投资较年初增加98.08%,主要原因是新增股权投资兴安县农村信用合作社联合社51万元;
    5、在建工程较年初减少60.62%,主要原因是报告期罗汉果烘烤项目完工后转固定资产;
    6、无形资产较年初增加136.78%,主要原因是报告期新增土地使用权;
    7、短期借款较年初增加40.89%,主要原因是新增银行贷款;
    8、预收账款较年初减少58.88%,主要原因是原预收款已发货确认销售;
    9、其他应付款较年初增加154.34%,主要原因是新增尚未结算的工程款项;
    10、其他非流动负债较年初增加247.93%,主要原因是收到财政拨付的工业发展扶持资金;
    11、报告期末总资产比期初增长106.67%,主要原因是报告期发行新股募集资金,净资产大幅增加;
    3.1.2报告期内公司利润及利润分配表项目大幅度变动及原因:

          项目                 本期           上年同期     增减金额( )     增减( %)
      销售费用              6,590,013.21    4,713,161.60     1,876,851.61          39.82%
      财务费用              3,179,748.75    1,628,312.93     1,551,435.82          95.28%
      营业外支出              766,673.46      179,586.01       587,087.45         326.91%
    少数股东损益               -8,955.47      -48,339.46        39,383.99         439.78%

    1、销售费用同比增加39.82%,主要原因是报告期内公司为更好的开拓国际市场的终端客户,导致参展费用大幅增加;
    2、财务费用同比增加95.28%,主要原因是报告期内公司发生汇兑损失91.50万元,以及扶贫贴息贷款到期,恢复正常贷款利率所致;
    3、营业外支出同比增加326.91%,主要原因是报告期内公司处理固定资产报废损失64.07万元。
    4、少数股东损益同比增加439.78%,主要原因是报告期子公司业绩改善;
    3.1.3报告期内公司现金流量表项目大幅度变动及原因:

                项目                            本期                 上年同期           增减金额( )         增减( %)
经营活动产生的现金流量净额                   -2,083,803.44           5,172,690.63        -7,256,494.07             -140.28%
投资活动产生的现金流量净额                 -29,858,067.21          -19,093,711.74       -10,764,355.47              -56.38%
筹资活动产生的现金流量净额                  162,257,978.96           4,658,824.90       157,599,154.06             3382.81%

    1、报告期经营活动产生的现金流量净额比上年同期减少140.28%,主要原因是:一、报告期公司支付到期的信用证增加导致购买商品、接受劳务支付的现金比上年同期增加575.7万元;二、支付给职工以及为职工支付的现金比上年同期增加119万元。
    2、报告期投资活动产生的现金流量净额比上年同期减少56.38%,主要原因是:报告期公司支付土地款2014.4万元。
    3、报告期筹资活动产生的现金流量净额比上年同期增长3382.81%,主要原因是:报告期公司发行新股募集资金,导致筹资活动产生的现金净流入大幅增加。
    3.2重大事项进展情况及其影响和解决方案的分析说明
    □适用√不适用
    3.3公司、股东及实际控制人承诺事项履行情况
    √适用□不适用
    控股股东秦本军及股东蒋安明承诺自公司股票上市之日起三十六个月内,不转让或委托他人管理其持有的发行人股票,也不由发行人回购其持有的发行人股票;其他发起人股东均承诺自公司股票上市之日起十二个月内不转让所持有的公司股票。报告期间公司发起人股东均严格履行了上述承诺。
    3.4对2007年度经营业绩的预计

                                                                                                        单位:(人民币)元
   对2007年度经营业绩的净利润比上年增减变动幅度小于30%
   预计                         公司预计2007年业绩与上年相比不会发生大幅变动
   2006年度经营业绩             净利润(已按新会计准则调整)                                                     22,340,630.46
                                公司的经营平稳有序进行,尚无可预见的事项导致公司业绩发生重大变动。如在公
   业绩变动的原因说明           司第四季度实际运行过程中,发生导致公司全年业绩超出上述预计的事项,公司将
                                及时履行披露义务。

    3.5证券投资情况
    □适用√不适用
    4附录
    4.1资产负债表
    编制单位:桂林莱茵生物科技股份有限公司                         2007年09月30日                        单位:(人民币)元

                                                   期末数                                        期初数
             项目
                                         合并                 母公司                  合并                  母公司
流动资产:
  货币资金                              155,915,455.40         155,913,750.84          26,514,193.53         26,507,170.88
  结算备付金
  拆出资金
  交易性金融资产
  应收票据
  应收账款                               37,616,937.54          37,616,937.54          20,085,656.06         20,085,656.06
  预付款项                                2,581,441.32           2,581,441.32           2,742,986.37          2,742,986.37
  应收保费
  应收分保账款
  应收分保合同准备金
  应收利息
  其他应收款                              4,993,828.02           4,978,084.44           3,478,929.27          3,463,847.22
  买入返售金融资产
  存货                                   57,495,153.12          57,295,756.97          50,462,172.50         50,271,160.97
  一年内到期的非流动资产
  其他流动资产
流动资产合计                            258,602,815.40         258,385,971.11         103,283,937.73        103,070,821.50
非流动资产:
  发放贷款及垫款
  可供出售金融资产
  持有至到期投资
  长期应收款
  长期股权投资                            1,030,000.00           6,430,000.00             520,000.00          5,920,000.00
  投资性房地产
  固定资产                               53,065,223.87          50,686,901.08          48,696,976.72         46,101,825.74
  在建工程                                  451,311.65             451,311.65           1,146,168.20          1,146,168.20
  工程物资
  固定资产清理
  生产性生物资产
  油气资产
  无形资产                               36,337,247.53          36,337,247.53          15,346,346.87         15,346,346.87
  开发支出
  商誉
  长期待摊费用
  递延所得税资产                            216,946.55             216,946.55             216,946.55            216,946.55
  其他非流动资产
非流动资产合计                           91,100,729.60          94,122,406.81          65,926,438.34         68,731,287.36
资产总计                                349,703,545.00         352,508,377.92         169,210,376.07        171,802,108.86
流动负债:
  短期借款                               41,000,000.00          41,000,000.00          29,100,000.00         29,100,000.00
  向中央银行借款
  吸收存款及同业存放
  拆入资金
  交易性金融负债
  应付票据
  应付账款                               18,995,022.18          18,875,407.81          17,653,553.60         17,526,289.23
  预收款项                                2,627,225.90           2,627,225.90           6,389,573.62          6,389,573.62
  卖出回购金融资产款
  应付手续费及佣金
  应付职工薪酬                              836,816.16             734,720.53           2,007,628.47          1,905,532.84
  应交税费                                  486,215.94             478,299.14             618,292.25            631,350.98
  应付利息
  其他应付款                              5,879,021.21           6,003,150.57           2,311,462.44          2,298,720.88
  应付分保账款
  保险合同准备金
  代理买卖证券款
  代理承销证券款
  一年内到期的非流动负债
  其他流动负债                              180,000.00             180,000.00
流动负债合计                             70,004,301.39          69,898,803.95          58,080,510.38         57,851,467.55
非流动负债:
  长期借款                               29,426,127.00          29,426,127.00          29,251,040.00         29,251,040.00
  应付债券
  长期应付款
  专项应付款
  预计负债
  递延所得税负债
  其他非流动负债                          9,166,368.77           9,166,368.77           2,634,531.21          2,634,531.21
非流动负债合计                           38,592,495.77          38,592,495.77          31,885,571.21         31,885,571.21
负债合计                              108,596,797.16        108,491,299.72             89,966,081.59         89,737,038.76
所有者权益(或股东权益):
  实收资本(或股本)                     64,766,880.00          64,766,880.00          48,266,880.00         48,266,880.00
  资本公积                              133,661,034.86         133,661,034.86                  51.74                 51.74
  减:库存股
  盈余公积                                5,241,672.00           5,241,672.00           5,241,672.00          5,241,672.00
  一般风险准备
  未分配利润                             37,188,194.01          40,347,491.34          25,477,768.30         28,556,466.36
  外币报表折算差额
归属于母公司所有者权益合计              240,857,780.87         244,017,078.20          78,986,372.04         82,065,070.10
少数股东权益                                248,966.97                                   257,922.44
所有者权益合计                          241,106,747.84         244,017,078.20          79,244,294.48         82,065,070.10
负债和所有者权益总计                    349,703,545.00         352,508,377.92         169,210,376.07        171,802,108.86
法定代表人:秦本军                               财务负责人:周庆伟                         会计机构负责人:郑辉
4.2本报告期利润表
编制单位:桂林莱茵生物科技股份有限公司                          2007年7-9月                        单位:(人民币)元
                                                    本期                                       上年同期
             项目
                                         合并                 母公司                  合并                  母公司
一、营业总收入                           26,712,669.02          26,712,669.02          31,507,574.83         31,501,113.29
其中:营业收入                           26,712,669.02          26,712,669.02         31,507,574.830         31,501,113.29
       利息收入
       已赚保费
       手续费及佣金收入
二、营业总成本                           23,128,533.17          23,117,925.38          27,079,387.38         26,894,827.51
其中:营业成本                           15,315,366.88          15,428,787.23          20,554,073.93         20,547,931.53
       利息支出
       手续费及佣金支出
       退保金
       赔付支出净额
       提取保险合同准备金净

       保单红利支出
       分保费用
       营业税金及附加                       171,021.99             169,916.55             219,197.25            219,197.25
       销售费用                           3,050,633.17           3,050,633.17           2,204,525.89          2,204,525.89
       管理费用                           3,193,597.35           3,070,747.99           3,563,813.40          3,385,367.57
       财务费用                           1,397,913.78           1,397,840.44            537,776.91             537,805.27
       资产减值损失
  加:公允价值变动收益(损失
以“-”号填列)
       投资收益(损失以“-”号
                                              7,240.00               7,240.00
填列)
         其中:对联营企业和合
营企业的投资收益
     汇兑收益(损失以“-”号填
列)
三、营业利润(亏损以“-”号填
                                          3,591,375.85           3,601,983.64           4,428,187.45          4,606,285.78
列)
  加:营业外收入                             20,000.00              20,000.00             648,242.37            648,242.37
  减:营业外支出                            738,673.46             738,673.46              31,565.01             31,565.01
     其中:非流动资产处置损失               640,673.46             640,673.46
四、利润总额(亏损总额以“-”
                                          2,872,702.39           2,883,310.18           5,044,864.81          5,222,963.14
号填列)
  减:所得税费用                            170,010.17             170,010.17
五、净利润(净亏损以“-”号填
                                          2,702,692.22           2,713,300.01           5,044,864.81          5,222,963.14
列)
     归属于母公司所有者的净
                                          2,703,752.99           2,713,300.01           5,062,674.64          5,222,963.14
利润
     少数股东损益                            -1,060.77                                    -17,809.83
六、每股收益:
     (一)基本每股收益                           0.06                   0.06                   0.10                  0.11
     (二)稀释每股收益                           0.06                   0.06                   0.10                  0.11
法定代表人:秦本军                               财务负责人:周庆伟                         会计机构负责人:郑辉
4.3年初到报告期末利润表
编制单位:桂林莱茵生物科技股份有限公司                          2007年1-9月                        单位:(人民币)元
                                                    本期                                       上年同期
             项目
                                         合并                 母公司                  合并                  母公司
一、营业总收入                           97,844,489.75          97,844,489.75          90,721,259.87         90,714,798.33
其中:营业收入                           97,844,489.75          97,844,489.75          90,721,259.87         90,714,798.33
       利息收入
       已赚保费
       手续费及佣金收入
二、营业总成本                           77,945,432.00          77,855,877.26          71,540,869.05         71,053,012.88
其中:营业成本                           58,500,395.17          58,724,475.00          56,017,538.40         56,011,396.00
       利息支出
       手续费及佣金支出
       退保金
       赔付支出净额
       提取保险合同准备金净

       保单红利支出
       分保费用
       营业税金及附加                       689,601.48             688,496.04             749,583.61            749,583.61
       销售费用                           6,590,013.21           6,590,013.21           4,713,161.60          4,713,161.60
       管理费用                           8,638,380.08           8,325,922.54           8,432,272.51          7,950,083.75
       财务费用                           3,179,748.75           3,179,677.16           1,628,312.93          1,628,787.92
       资产减值损失                         347,293.31             347,293.31
  加:公允价值变动收益(损失
以“-”号填列)
       投资收益(损失以“-”号
                                             36,200.00              36,200.00              31,100.00             31,100.00
填列)
         其中:对联营企业和合
营企业的投资收益
     汇兑收益(损失以“-”号填
列)
三、营业利润(亏损以“-”号填
                                         19,935,257.75          20,024,812.49          19,211,490.82         19,692,885.45
列)
  加:营业外收入                            525,717.88             525,717.88             663,442.37            663,442.37
  减:营业外支出                            766,673.46             766,673.46             179,586.01            177,586.01
     其中:非流动资产处置损失
四、利润总额(亏损总额以“-”
                                         19,694,302.17          19,783,856.91          19,695,347.18         20,178,741.81
号填列)
  减:所得税费用                          1,499,381.35           1,499,381.35
五、净利润(净亏损以“-”号填
                                         18,194,920.82          18,284,475.56          19,695,347.18         20,178,741.81
列)
     归属于母公司所有者的净
                                         18,203,876.29          18,284,475.56          19,743,686.64         20,178,741.81
利润
     少数股东损益                            -8,955.47                                    -48,339.46
六、每股收益:
     (一)基本每股收益                           0.38                   0.38                   0.41                  0.42
     (二)稀释每股收益                           0.38                   0.38                   0.41                  0.42
法定代表人:秦本军                               财务负责人:周庆伟                         会计机构负责人:郑辉
4.4年初到报告期末现金流量表
编制单位:桂林莱茵生物科技股份有限公司                          2007年1-9月                        单位:(人民币)元
                                                    本期                                       上年同期
             项目
                                         合并                 母公司                  合并                  母公司
一、经营活动产生的现金流量:
     销售商品、提供劳务收到的
                                         80,529,235.42          80,529,235.42          83,518,237.00         83,509,837.00
现金
     客户存款和同业存放款项
净增加额
     向中央银行借款净增加额
     向其他金融机构拆入资金
净增加额
     收到原保险合同保费取得
的现金
     收到再保险业务现金净额
     保户储金及投资款净增加

     处置交易性金融资产净增
加额
     收取利息、手续费及佣金的
现金
     拆入资金净增加额
     回购业务资金净增加额
     收到的税费返还                         687,461.13             687,461.13             189,100.78            189,100.78
     收到其他与经营活动有关
                                          4,003,103.13           4,003,099.72           2,075,112.28          1,974,401.69
的现金
       经营活动现金流入小计              85,219,799.68          85,219,796.27          85,782,450.06          85,673,339.47
     购买商品、接受劳务支付的
                                         60,644,344.74          60,657,004.74          54,887,405.62          54,822,221.62
现金
     客户贷款及垫款净增加额
     存放中央银行和同业款项
净增加额
     支付原保险合同赔付款项
的现金
     支付利息、手续费及佣金的
现金
     支付保单红利的现金
     支付给职工以及为职工支
                                          7,346,178.78           7,344,506.11           6,156,020.08           5,998,161.67
付的现金
     支付的各项税费                       5,587,472.62           5,573,291.79           5,645,200.42           5,645,193.96
     支付其他与经营活动有关
                                         13,725,606.98          13,723,478.98          13,921,133.31          13,807,017.21
的现金
       经营活动现金流出小计              87,303,603.12          87,298,281.62          80,609,759.43          80,272,594.46
         经营活动产生的现金
                                         -2,083,803.44          -2,078,485.35           5,172,690.63           5,400,745.01
流量净额
二、投资活动产生的现金流量:
     收回投资收到的现金
     取得投资收益收到的现金                  36,200.00              36,200.00              31,100.00              31,100.00
     处置固定资产、无形资产和
其他长期资产收回的现金净额
     处置子公司及其他营业单
位收到的现金净额
     收到其他与投资活动有关
的现金
       投资活动现金流入小计                  36,200.00              36,200.00              31,100.00              31,100.00
     购建固定资产、无形资产和
                                         29,384,267.21          29,384,267.21           6,924,811.74           6,876,181.74
其他长期资产支付的现金
     投资支付的现金                         510,000.00             510,000.00
     质押贷款净增加额
     取得子公司及其他营业单
位支付的现金净额
     支付其他与投资活动有关
                                                                                       12,200,000.00          12,200,000.00
的现金
       投资活动现金流出小计              29,894,267.21          29,894,267.21          19,124,811.74          19,076,181.74
         投资活动产生的现金
                                        -29,858,067.21         -29,858,067.21         -19,093,711.74         -19,045,081.74
流量净额
  三、筹资活动产生的现金流
量:
     吸收投资收到的现金                 155,025,750.00         155,025,750.00
     其中:子公司吸收少数股东
投资收到的现金
     取得借款收到的现金                  49,900,000.00          49,900,000.00          72,500,000.00          72,500,000.00
     发行债券收到的现金
     收到其他与筹资活动有关
                                          6,320,000.00           6,320,000.00             548,810.00             548,810.00
的现金
       筹资活动现金流入小计             211,245,750.00         211,245,750.00          73,048,810.00          73,048,810.00
     偿还债务支付的现金                  38,000,000.00          38,000,000.00          64,650,000.00          64,650,000.00
     分配股利、利润或偿付利息
                                          7,306,651.67           7,306,651.67           3,636,745.10           3,636,745.10
支付的现金
     其中:子公司支付给少数股
东的股利、利润
     支付其他与筹资活动有关
                                          3,681,119.37           3,681,119.37             103,240.00             103,240.00
的现金
       筹资活动现金流出小计              48,987,771.04          48,987,771.04          68,389,985.10          68,389,985.10
         筹资活动产生的现金
                                        162,257,978.96         162,257,978.96           4,658,824.90           4,658,824.90
流量净额
四、汇率变动对现金及现金等价
                                           -914,846.44            -914,846.44
物的影响
五、现金及现金等价物净增加额            129,401,261.87         129,406,579.96          -9,262,196.21          -8,985,511.83
     加:期初现金及现金等价物
                                         26,514,193.53          26,507,170.88          12,923,560.61          12,608,953.77
余额
六、期末现金及现金等价物余额            155,915,455.40         155,913,750.84           3,661,364.40           3,623,441.94

    法定代表人:秦本军                               财务负责人:周庆伟                         会计机构负责人:郑辉
    4.5审计报告
    审计意见:未经审计。



    桂林莱茵生物科技股份有限公司
    董事长:秦本军
    二○○七年十月二十七日
数据加载中...
prevnext
手机查看股票